Trevor Hawkins, Kevin Conroy, Maneesh Arora, James Herrman, Gregory Hamilton, John Bellano, Jake Orville, Molecular Devices, S&P, Pacific Growth Equities, Jivan, NimbleGen, 454 Life Sciences, FDA, Affy, Iconix | GenomeWeb


Trevor Hawkins stepped down this week as president and CEO of MDS to take a position in Europe with Phillips. Hawkins has also resigned from the board of Tm Bioscience.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.